Trial intelligence / Profile preview

Ketamine vs Dexmedetomidine in Scalp Block for Brain Tumor Surgery

NCT07698665Recruiting

Sponsor
Cairo University
Start
Jan 2026
Primary completion
Jul 2026
Countries
1
01

Overview

Randomised, double-blind trial in acute pain comparing Dexmedetomidine (D) with Ketamine (K) (2 arms). Primary endpoint: Analgesic efficacy of dexmedetomidine versus ketamine as adjuvants in scalp blocks at 6 hours. Started Jan 2026; status: recruiting.

02

Drugs

ketaminedexmedetomidine
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT07698665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07698665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call